EMA Application withdrawn: Insulin Human Rechon (Insulin human) — Rechon Life Science AB

View source ↗

Summary

The EMA has withdrawn the marketing authorization application for Insulin Human Rechon (insulin human) by Rechon Life Science AB for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin Human Rechon (insulin human)

Snippet

Status: Application withdrawn. Therapeutic area: Diabetes Mellitus. MAH: Rechon Life Science AB